dostarlimab
gsk
['gyn', 'dostarlimab', 'ruby']
an analysis of patient-reported outcomes in the phase 3 ruby trial supports dostarlimab use in patients with primary advanced or recurrent endometrial cancer. #oncology #nursing #gyncsm #asco23 
Capturing the voice of nursing professionals in the oncology news landscape.